The efficacy of prophylactic interferon alfa‐2b in preventing recurrent hepatitis C after liver transplantation

Clinical recurrence of hepatitis C after liver transplantation can lead to cirrhosis, liver failure, and death. In patients undergoing liver transplantation for hepatitis C, we assessed the efficacy of interferon alfa‐2b (IFN) in preventing recurrent hepatitis. We randomized 86 patients to either an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 1998-09, Vol.28 (3), p.831-838
Hauptverfasser:	Sheiner, Patricia A., Boros, Peter, Klion, Franklin M., Thung, Swan N., Schluger, Leona Kim, Lau, Johnson Y., Mor, Eytan, Bodian, Carol, Guy, Stephen R., Schwartz, Myron E., Emre, Sukru, Bodenheer, Henry C., Miller, Charles M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences Female Hepatitis C - prevention & control Humans Immunomodulators Interferon-alpha - therapeutic use Liver - physiopathology Liver Transplantation - adverse effects Male Medical sciences Middle Aged Pharmacology. Drug treatments Prospective Studies Recombinant Proteins Recurrence RNA, Viral - blood Viremia - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!